Gomez CM - Search Results

1

Gait Variability in Spinocerebellar Ataxia Assessed Using Wearable Inertial Sensors.

Shah VV, Rodriguez-Labrada R, Horak FB, McNames J, Casey H, Hansson Floyd K, El-Gohary M, Schmahmann JD, Rosenthal LS, Perlman S, Velázquez-Pérez L, Gomez CM. Shah VV, et al. Among authors: gomez cm. Mov Disord. 2021 Dec;36(12):2922-2931. doi: 10.1002/mds.28740. Epub 2021 Aug 23. Mov Disord. 2021. PMID: 34424581

2

Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia.

Ranum LP, Lundgren JK, Schut LJ, Ahrens MJ, Perlman S, Aita J, Bird TD, Gomez C, Orr HT. Ranum LP, et al. Am J Hum Genet. 1995 Sep;57(3):603-8. Am J Hum Genet. 1995. PMID: 7668288 Free PMC article.

3

Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset.

Gomez CM, Thompson RM, Gammack JT, Perlman SL, Dobyns WB, Truwit CL, Zee DS, Clark HB, Anderson JH. Gomez CM, et al. Ann Neurol. 1997 Dec;42(6):933-50. doi: 10.1002/ana.410420616. Ann Neurol. 1997. PMID: 9403487

4

Clinical feature profile of spinocerebellar ataxia type 1-8 predicts genetically defined subtypes.

Maschke M, Oehlert G, Xie TD, Perlman S, Subramony SH, Kumar N, Ptacek LJ, Gomez CM. Maschke M, et al. Among authors: gomez cm. Mov Disord. 2005 Nov;20(11):1405-12. doi: 10.1002/mds.20533. Mov Disord. 2005. PMID: 16037936

5

Antioxidant use in Friedreich ataxia.

Myers L, Farmer JM, Wilson RB, Friedman L, Tsou A, Perlman SL, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews KD, Balcer LJ, Lynch DR. Myers L, et al. Among authors: gomez cm. J Neurol Sci. 2008 Apr 15;267(1-2):174-6. doi: 10.1016/j.jns.2007.10.008. Epub 2007 Nov 7. J Neurol Sci. 2008. PMID: 17988688 Free PMC article. Clinical Trial.

6

Impaired eye movements in presymptomatic spinocerebellar ataxia type 6.

Christova P, Anderson JH, Gomez CM. Christova P, et al. Among authors: gomez cm. Arch Neurol. 2008 Apr;65(4):530-6. doi: 10.1001/archneur.65.4.530. Arch Neurol. 2008. PMID: 18413478

7

Health related quality of life measures in Friedreich Ataxia.

Epstein E, Farmer JM, Tsou A, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews K, Wilson RB, Balcer LJ, Lynch DR. Epstein E, et al. Among authors: gomez cm. J Neurol Sci. 2008 Sep 15;272(1-2):123-8. doi: 10.1016/j.jns.2008.05.009. Epub 2008 Jun 20. J Neurol Sci. 2008. PMID: 18571673

8

Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.

Friedman LS, Farmer JM, Perlman S, Wilmot G, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Balcer LJ, Wilson RB, Lynch DR. Friedman LS, et al. Among authors: gomez cm. Mov Disord. 2010 Mar 15;25(4):426-32. doi: 10.1002/mds.22912. Mov Disord. 2010. PMID: 20063431 Free PMC article.

9

Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status.

Oz G, Hutter D, Tkác I, Clark HB, Gross MD, Jiang H, Eberly LE, Bushara KO, Gomez CM. Oz G, et al. Among authors: gomez cm. Mov Disord. 2010 Jul 15;25(9):1253-61. doi: 10.1002/mds.23067. Mov Disord. 2010. PMID: 20310029 Free PMC article.

10

Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants.

Regner SR, Wilcox NS, Friedman LS, Seyer LA, Schadt KA, Brigatti KW, Perlman S, Delatycki M, Wilmot GR, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Ravina B, Brocht A, Farmer JM, Lynch DR. Regner SR, et al. Among authors: gomez cm. J Child Neurol. 2012 Sep;27(9):1152-8. doi: 10.1177/0883073812448462. Epub 2012 Jun 29. J Child Neurol. 2012. PMID: 22752494 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

307 results

Search Page